Book covered I hear and will close this Friday so sounds like will be scaling
Emerald had a very good year in 2019 with clinics in Australia expanding rapidly and the company’s first medical data deals completed with Zelda (Zelira) and Canopy Growth, the world’s largest cannabis company. In 2020, Emerald plans to open more clinics in Australia and its first in the UK. Emerald’s detailed data collection from patient cannabinoid treatments has now attracted a great deal of interest from potential partners. The FDA is actively closing down producers who do not have medical proof around their products (https://viewpoints.reedsmith.com/po...ctices-leads-to-yet-another-class-action-suit). Doctors are asking for medical evidence before widely prescribing and health insurers will only pay for products where there is data to demonstrate the effectiveness in patients. This puts Emerald in a very valuable position.
- Forums
- ASX - By Stock
- EMD
- IPO - Emerald Clinics Limited
IPO - Emerald Clinics Limited, page-21
- There are more pages in this discussion • 37 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add EMD (ASX) to my watchlist
(20min delay)
|
|||||
Last
5.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $18.69M |
Open | High | Low | Value | Volume |
5.0¢ | 5.1¢ | 4.9¢ | $17.76K | 359.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 204081 | 4.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.1¢ | 42827 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 204081 | 0.049 |
2 | 29191 | 0.048 |
1 | 11000 | 0.047 |
1 | 200000 | 0.046 |
2 | 111155 | 0.045 |
Price($) | Vol. | No. |
---|---|---|
0.051 | 42827 | 2 |
0.052 | 65193 | 1 |
0.053 | 10000 | 1 |
0.062 | 51000 | 1 |
0.064 | 125693 | 2 |
Last trade - 15.59pm 06/05/2024 (20 minute delay) ? |
|
|||||
Last
4.9¢ |
  |
Change
0.000 ( 0.00 %) |
|||
Open | High | Low | Volume | ||
5.0¢ | 5.0¢ | 4.9¢ | 39731 | ||
Last updated 12.36pm 06/05/2024 ? |
Featured News
EMD (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, CEO
Steven Gourlay
CEO
Previous Video
Next Video
SPONSORED BY The Market Online